‘Catalytic’ doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: a small meta-analysis of randomised controlled feeding trials

‘Catalytic’ doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: a small meta-analysis of randomised controlled feeding trials

Contrary to concerns that fructose may have adverse metabolic effects, there is evidence that small, ‘catalytic’ doses ( ≤ 10 g/meal) of fructose decrease the glycaemic response to high-glycaemic index meals in human subjects. To assess the longer-term effects of ‘catalytic’ doses of fructose, we un...

Full description

Bibliographic Details
Main Authors: Sievenpiper, John L., Chiavaroli, Laura, de Souza, Russell J., Mirrahimi, Arash, Cozma, Adrian I., Ha, Vanessa, Wang, D. David, Yu, Matthew E., Carleton, Amanda J., Beyene, Joseph, Di Buono, Marco, Jenkins, Alexandra L., Leiter, Lawrence A., Wolever, Thomas M. S., Kendall, Cyril W. C., Jenkins, David J. A.
Format: Online
Language:English
Published: Cambridge University Press 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411192/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411192/

Similar Items